Successful Coronary Interventions with the Aid of Abciximab (ReoPro (R)) in High-Risk Patients: Report of Two Cases.
- Author:
Woo Suck PARK
1
;
Myung Ho JEONG
;
Nam Ho KIM
;
Young Keun AHN
;
Youl BAE
;
Gwang Chae GILL
;
Joo Hyung PARK
;
Jeong Gwan CHO
;
Jong Chun PARK
;
Jung Chaee KANG
Author Information
1. Department of Internal Medicine, Chonnam University Medical School, Kwangju, Korea.
- Publication Type:Case Report
- Keywords:
High risk patient;
Coronary intervention;
Abciximab
- MeSH:
Angioplasty;
Coronary Vessels;
Glycoproteins;
Humans
- From:The Korean Journal of Critical Care Medicine
1998;13(2):254-260
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Abrupt closure of coronary artery during coronary intervention is one of major limitations especially in high-risk patients. Platelets are responsible for composing acute thrombotic occlusion at the site of therapeutic arterial injury. Abciximab (platelet glycoprotein IIb/IIIa receptor blocker) might be helpful in preventing the acute thrombotic occlusion. We experienced an excellent effects of the drug in two cases of high-risk patients, unsuccessful thrombolytics and PTCA with acute occlusion. With additional use of abciximab we overcame the complications and succeeded in getting normal coronary flow and resultant successful angioplasties.
